| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
14,788 |
12,531 |
$1.05M |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
7,320 |
6,451 |
$329K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
36,339 |
5,935 |
$291K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,541 |
1,523 |
$234K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
606 |
577 |
$221K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,895 |
1,846 |
$215K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,471 |
2,265 |
$211K |
| 0681 |
|
38 |
38 |
$205K |
| 99070 |
|
801 |
609 |
$199K |
| 0250 |
|
16,745 |
5,899 |
$199K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
9,960 |
8,304 |
$133K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
818 |
815 |
$129K |
| 71045 |
Radiologic examination, chest; single view |
3,412 |
3,205 |
$115K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,210 |
1,016 |
$97K |
| 71046 |
Radiologic examination, chest; 2 views |
2,826 |
2,747 |
$81K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,379 |
864 |
$80K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,669 |
9,671 |
$76K |
| 93308 |
|
782 |
751 |
$74K |
| 84484 |
|
5,011 |
4,541 |
$73K |
| 99199 |
Unlisted special service, procedure or report |
754 |
675 |
$72K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,862 |
1,598 |
$69K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,053 |
1,030 |
$54K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
534 |
527 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
5,045 |
4,572 |
$44K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,390 |
1,262 |
$43K |
| 80053 |
Comprehensive metabolic panel |
1,709 |
1,603 |
$40K |
| 83690 |
|
2,791 |
2,567 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,421 |
1,189 |
$37K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
496 |
449 |
$37K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,994 |
910 |
$35K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,998 |
1,221 |
$31K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,584 |
1,948 |
$28K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
740 |
718 |
$25K |
| 82962 |
|
2,068 |
1,653 |
$24K |
| 71250 |
|
426 |
424 |
$23K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
396 |
393 |
$23K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
720 |
681 |
$21K |
| J3490 |
Unclassified drugs |
611 |
377 |
$19K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
919 |
519 |
$19K |
| 83605 |
|
1,308 |
1,213 |
$18K |
| 81003 |
|
3,935 |
3,726 |
$18K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,181 |
1,117 |
$18K |
| 90837 |
Psychotherapy, 53 minutes with patient |
382 |
185 |
$17K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
519 |
504 |
$16K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
377 |
346 |
$16K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
519 |
504 |
$16K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
108 |
108 |
$15K |
| 86703 |
|
1,109 |
1,092 |
$14K |
| 94060 |
|
117 |
117 |
$14K |
| 85027 |
|
2,092 |
1,988 |
$14K |
| 73030 |
|
636 |
613 |
$13K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,022 |
2,945 |
$13K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,243 |
1,148 |
$13K |
| 86803 |
|
1,865 |
1,850 |
$13K |
| 70498 |
|
27 |
26 |
$12K |
| 86900 |
|
544 |
535 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
566 |
549 |
$11K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
235 |
191 |
$10K |
| 92553 |
|
199 |
199 |
$10K |
| 73562 |
|
428 |
418 |
$8K |
| 70496 |
|
27 |
26 |
$8K |
| 76770 |
|
125 |
125 |
$8K |
| 73630 |
|
446 |
423 |
$8K |
| 0450 |
Emergency room services |
249 |
214 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
487 |
478 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,738 |
1,625 |
$7K |
| 93971 |
|
87 |
87 |
$6K |
| 73502 |
|
282 |
271 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
748 |
734 |
$6K |
| 80061 |
Lipid panel |
396 |
386 |
$6K |
| 87088 |
|
1,717 |
1,647 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
85 |
85 |
$6K |
| 85610 |
|
1,569 |
1,543 |
$5K |
| 73564 |
|
176 |
156 |
$5K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
186 |
151 |
$5K |
| 83880 |
|
380 |
369 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
12 |
12 |
$5K |
| 73110 |
|
212 |
192 |
$5K |
| 87490 |
|
250 |
234 |
$4K |
| 91200 |
|
108 |
108 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,687 |
779 |
$4K |
| 86850 |
|
542 |
534 |
$4K |
| 73560 |
|
167 |
158 |
$4K |
| 87590 |
|
250 |
234 |
$4K |
| 72100 |
|
145 |
145 |
$4K |
| 81001 |
|
1,423 |
1,351 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
834 |
590 |
$4K |
| 86901 |
|
544 |
535 |
$4K |
| 76604 |
|
147 |
143 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
81 |
78 |
$3K |
| 82803 |
|
141 |
127 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
76 |
49 |
$3K |
| 73610 |
|
154 |
148 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
58 |
44 |
$3K |
| 72170 |
|
163 |
162 |
$3K |
| 96415 |
|
76 |
62 |
$3K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
113 |
112 |
$3K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
34 |
31 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
236 |
116 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
149 |
128 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,455 |
1,291 |
$2K |
| 81025 |
|
304 |
278 |
$2K |
| 93970 |
|
26 |
25 |
$2K |
| 73130 |
|
115 |
108 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
86 |
84 |
$2K |
| 87341 |
|
292 |
291 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
13 |
$2K |
| 86480 |
|
35 |
35 |
$2K |
| 87040 |
|
240 |
231 |
$2K |
| 93017 |
|
96 |
96 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
876 |
817 |
$2K |
| 77066 |
Tomosynthesis, mammo |
53 |
53 |
$1K |
| 84439 |
|
119 |
111 |
$1K |
| 90686 |
|
162 |
161 |
$1K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
25 |
25 |
$1K |
| 86140 |
|
307 |
298 |
$1K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$1K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
386 |
238 |
$1K |
| 93925 |
|
12 |
12 |
$905.91 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
83 |
82 |
$865.45 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
49 |
49 |
$853.57 |
| 87077 |
|
160 |
159 |
$851.77 |
| 94618 |
|
60 |
60 |
$847.69 |
| 94729 |
|
104 |
104 |
$684.39 |
| 85379 |
|
64 |
63 |
$665.95 |
| 84100 |
|
26 |
24 |
$663.05 |
| 93289 |
|
36 |
36 |
$649.51 |
| 82043 |
|
86 |
86 |
$554.34 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
13 |
13 |
$539.63 |
| 94726 |
|
54 |
54 |
$538.16 |
| 93922 |
|
57 |
56 |
$492.61 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
246 |
245 |
$480.08 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
103 |
95 |
$473.44 |
| 82274 |
|
27 |
27 |
$439.60 |
| 85652 |
|
161 |
158 |
$422.92 |
| 87186 |
|
177 |
174 |
$381.03 |
| 36593 |
|
13 |
12 |
$378.88 |
| 82565 |
|
80 |
78 |
$358.45 |
| 76642 |
|
14 |
13 |
$337.67 |
| 73590 |
|
27 |
25 |
$320.36 |
| 82040 |
|
26 |
26 |
$319.37 |
| 82607 |
|
64 |
64 |
$270.76 |
| J3535 |
Drug administered through a metered dose inhaler |
29 |
29 |
$258.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
118 |
103 |
$210.46 |
| 73552 |
|
15 |
15 |
$166.47 |
| 73080 |
|
15 |
15 |
$161.46 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
118 |
114 |
$154.83 |
| 82550 |
|
49 |
42 |
$132.33 |
| 86706 |
|
28 |
28 |
$118.75 |
| 82310 |
|
40 |
40 |
$112.34 |
| 82247 |
|
41 |
40 |
$109.93 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
117 |
101 |
$104.02 |
| 82728 |
|
15 |
13 |
$101.08 |
| 84460 |
|
68 |
68 |
$99.11 |
| 84466 |
|
14 |
14 |
$82.80 |
| 83540 |
|
15 |
15 |
$78.99 |
| 11721 |
|
15 |
15 |
$53.14 |
| 94760 |
|
78 |
52 |
$46.93 |
| G0008 |
Administration of influenza virus vaccine |
71 |
71 |
$36.78 |
| 82947 |
|
44 |
44 |
$23.08 |
| 84145 |
|
12 |
12 |
$22.21 |
| 84295 |
|
40 |
40 |
$8.32 |
| 87081 |
|
44 |
43 |
$5.68 |
| 84075 |
|
36 |
36 |
$5.18 |
| 82374 |
|
38 |
38 |
$4.88 |
| 84520 |
|
39 |
39 |
$3.95 |
| 90688 |
|
29 |
29 |
$0.04 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
13 |
13 |
$0.00 |
| 0250R |
|
355 |
272 |
$0.00 |
| G0410 |
Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes |
2,420 |
315 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
82 |
68 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
15 |
12 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
12 |
12 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
13 |
13 |
$0.00 |